Luas Diagnostics

Guildford, United Kingdom Founded: 2020 • Age: 6 yrs
Sensors and connected app are developed for diabetes management.
Request Access

About Luas Diagnostics

Luas Diagnostics is a company based in Guildford (United Kingdom) founded in 2020.. Luas Diagnostics has raised $949.08 thousand across 4 funding rounds. The company has 3 employees as of June 30, 2022. Luas Diagnostics offers products and services including Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests. Luas Diagnostics operates in a competitive market with competitors including Dexcom, Livongo, Bigfoot Biomedical, Prenetics and Senseonics, among others.

  • Headquarter Guildford, United Kingdom
  • Employees 3 as on 30 Jun, 2022
  • Stage Minicorn
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Luas Diagnostics Ltd
  • Date of Incorporation 08 Jun, 2020
  • Jurisdiction LONDON, ENGLAND
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Extended, Virtual & Augmented Reality
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $949.08 K (USD)

    in 4 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    3

    as on Jun 30, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Luas Diagnostics

Luas Diagnostics offers a comprehensive portfolio of products and services, including Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Home-to-laboratory test for Group B Streptococcus in pregnancy.

Single-use self-test for detecting HIV-1 and HIV-2 antibodies.

Range of tests for various infectious diseases at home or professionally.

Tests for early detection of cancer to improve clinical outcomes.

People of Luas Diagnostics
Headcount 1-10
Employee Profiles 1
Employee Profiles
People
Brendan Farrell
Founder & Executive Chairman

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Luas Diagnostics

Luas Diagnostics has successfully raised a total of $949.08K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round
  • First Round

    (29 Sep 2020)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2023 Amount Seed - Luas Diagnostics Valuation

investors

Apr, 2021 Amount Seed - Luas Diagnostics Valuation

investors

Jan, 2021 Amount Seed - Luas Diagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Luas Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Luas Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Luas Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Luas Diagnostics

Luas Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Bigfoot Biomedical, Prenetics and Senseonics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Wearable glucose monitoring patches are provided for real-time data tracking.
domain founded_year HQ Location
Provider of smart devices for diabetes management for patients and doctors
domain founded_year HQ Location
Developer of a closed-loop automated insulin delivery system
domain founded_year HQ Location
Health risks are identified through online genetic and diagnostic testing.
domain founded_year HQ Location
Implantable continuous glucose monitoring systems are provided for diabetes management.
domain founded_year HQ Location
Provider of workforce healthcare solutions
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Luas Diagnostics

Frequently Asked Questions about Luas Diagnostics

When was Luas Diagnostics founded?

Luas Diagnostics was founded in 2020.

Where is Luas Diagnostics located?

Luas Diagnostics is headquartered in Guildford, United Kingdom.

Is Luas Diagnostics a funded company?

Luas Diagnostics is a funded company, having raised a total of $949.08K across 4 funding rounds to date. The company's 1st funding round was a Seed of $416.77K, raised on Sep 29, 2020.

How many employees does Luas Diagnostics have?

As of Jun 30, 2022, the latest employee count at Luas Diagnostics is 3.

What does Luas Diagnostics do?

Founded in 2020 and based in Guildford, United Kingdom, operations are focused on the health diagnostics sector. Sensors and a connected app are developed for diabetes management. A portable diagnostic device is utilized to detect enzyme-substrate complexes on electrodes in glucose monitors. Presence of drugs or metabolites in samples is identified at the electrode, with no drug sample required in the tested material.

Who are the top competitors of Luas Diagnostics?

Luas Diagnostics's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.

What products or services does Luas Diagnostics offer?

Luas Diagnostics offers Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests.

What is Luas Diagnostics's valuation?

The valuation of Luas Diagnostics is $3.01M as of Apr 2023.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available